Rosemary Harrison - 10 Jan 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC.

Role
Chief Business & Strategy
Signature
/s/ Margaret Siegel as Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
10 Jan 2022
Net transactions value
$0
Form type
4
Filing time
12 Jan 2022, 05:57:06 UTC
Previous filing
19 Nov 2021
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (Right to Buy) Award $0 +191,102 $0.000000 191,102 10 Jan 2022 Common Stock 191,102 $4.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on January 10, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.